Your browser doesn't support javascript.
loading
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial.
Thieblemont, Catherine; Phillips, Tycel; Ghesquieres, Herve; Cheah, Chan Y; Clausen, Michael Roost; Cunningham, David; Do, Young Rok; Feldman, Tatyana; Gasiorowski, Robin; Jurczak, Wojciech; Kim, Tae Min; Lewis, David John; van der Poel, Marjolein; Poon, Michelle Limei; Cota Stirner, Mariana; Kilavuz, Nurgul; Chiu, Christopher; Chen, Menghui; Sacchi, Mariana; Elliott, Brian; Ahmadi, Tahamtan; Hutchings, Martin; Lugtenburg, Pieternella J.
Afiliação
  • Thieblemont C; Assistance Publique & Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris, France.
  • Phillips T; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.
  • Ghesquieres H; Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.
  • Cheah CY; Sir Charles Gairdner Hospital, Perth, Australia.
  • Clausen MR; Division of Internal Medicine, Medical School, University of Western Australia, Perth, Australia.
  • Cunningham D; Vejle Hospital, Vejle, Denmark.
  • Do YR; The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.
  • Feldman T; Keimyung University Dongsan Medical Center, Daegu, Republic of Korea.
  • Gasiorowski R; Hackensack Meridian Health Hackensack University Medical Center, Hackensack, NJ.
  • Jurczak W; Concord Hospital, University of Sydney, Sydney, Australia.
  • Kim TM; MSC National Research Institute of Oncology, Kraków, Poland.
  • Lewis DJ; Seoul National University Hospital, Seoul, Republic of Korea.
  • van der Poel M; University Hospitals Plymouth NHS Trust, Derriford Hospital, Plymouth, United Kingdom.
  • Poon ML; On behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Maastricht, Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Cota Stirner M; National University Hospital, Singapore.
  • Kilavuz N; AbbVie, North Chicago, IL.
  • Chiu C; Genmab, Princeton, NJ.
  • Chen M; Genmab, Princeton, NJ.
  • Sacchi M; Genmab, Princeton, NJ.
  • Elliott B; Genmab, Princeton, NJ.
  • Ahmadi T; Genmab, Princeton, NJ.
  • Hutchings M; Genmab, Princeton, NJ.
  • Lugtenburg PJ; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
J Clin Oncol ; 41(12): 2238-2247, 2023 04 20.
Article em En | MEDLINE | ID: mdl-36548927
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Receptores de Antígenos Quiméricos / Antineoplásicos Limite: Adult / Humans / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Receptores de Antígenos Quiméricos / Antineoplásicos Limite: Adult / Humans / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França